PLANT

Medtronic to buy Irish medical device maker Covidien

Will have executive offices in Dublin but operate in Minneapolis.

June 16, 2014   by ASSOCIATED PRESS

MINNEAPOLIS — US medical device manufacturer Medtronic has agreed to buy Ireland-based competitor Covidien for $42.9 billion in cash and stock.

The combined company would have its executive offices in Dublin, where it could benefit from Ireland’s lower corporate tax rates. But the merged company would continue to operate in Minneapolis, where Medtronic employs more than 8,000, the companies said in a statement.

Medtronic is paying a 29% premium on Covidien’s stock price.

The deal is the latest in a series of acquisitions by medical-device manufacturers. The companies are seeking to expand their offerings and contain costs in response to price curbs forced by the nation’s new health care law.

In April, Zimmer Holdings, an orthopedic device maker, announced that it was buying Biomet in a $13 billion deal.

Medtronic makes pacemakers and insulin pumps, among other products. Covidien specializes in surgical equipment.

As a result of savings from the deal, Medtronic said it would spend an additional $10 billion over the next decade in investments, acquisitions and research and development in the US.


Print this page

Related Stories

Leave a Reply

Your email address will not be published. Required fields are marked *

*